Marchex (MCHX) Cash & Equivalents (2010 - 2025)

Marchex (MCHX) has 16 years of Cash & Equivalents data on file, last reported at $9.9 million in Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $9.9 million, down 22.13% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.9 million (down 22.13% YoY), and the FY2025 annual result was $9.9 million, down 22.13% from the prior year.
• Cash & Equivalents fell to $9.9 million in Q4 2025 per MCHX's latest filing, from $10.3 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $28.2 million in Q1 2021 and troughed at $9.9 million in Q4 2025.
• A 5-year average of $17.6 million and a median of $14.4 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents slipped 10.77% in 2022, then slumped 43.1% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $27.1 million in 2021, then declined by 24.41% to $20.5 million in 2022, then declined by 28.66% to $14.6 million in 2023, then fell by 12.6% to $12.8 million in 2024, then declined by 22.13% to $9.9 million in 2025.
• Business Quant data shows MCHX's Cash & Equivalents at $9.9 million in Q4 2025, $10.3 million in Q3 2025, and $10.5 million in Q2 2025.